LRRK2 and Parkinson disease: Consistent with our previous report20, concentrations of all three BMP isoforms were significantly higher (3–7-fold) in LRRK2 G2019S+ carriers compared to HC and sPD, but the levels did not differ between the PD manifesting and NMC groups (Table 1a and Fig. 1).